Dune Medical lands $3.4m EU grant
Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant.
The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.”
“This 3 million euro grant will expedite bringing our soft tissue biopsy system to the market. It will provide radiologists and surgeons immediate graphic characterizations of tissue abnormalities along the tip of the biopsy needle, just before samples are taken. This real-time insight can help reduce the time t...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Oncology Dune Medical Devices Inc. Source Type: news
FDA adds new clearance for Cianna Medical ’ s Savi Scout breast cancer locator
Cianna Medical said today it won additional FDA 510(k) clearance for its Savi Scout radar localization breast cancer device, now cleared to be placed at the lumpectomy site up to 30 days prior to surgical removal.
Aliso Viejo, Calif.-based Cianna’s Savi Scout is designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures.
The surgeon uses a hand piece that emits infrared light and electromagnetic waves to locate a reflector placed in target tissue as long as a week before surgery. After reaching the surgical bulls-eye, the surgeon takes out the target...
Source: Mass Device - August 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Cianna Medical Source Type: news
Why More Mastectomies?
I understand that more women with newly diagnosed breast cancer are choosing mastectomies, even double mastectomies, over lumpectomy. I've also heard that mastectomy is now an outpatient procedure, which seems outrageous. Can you tell me why this is happening? (Source: Dr. Weil Q and A)
Source: Dr. Weil Q and A - July 12, 2016 Category: Consumer Health News Source Type: news
Ipsilateral arm BP measurements after breast cancer?
A 47-year-old woman with a history of right-sided breast cancer – status after lumpectomy, lymph node dissection, and radiation – comes in to clinic for evaluation. She asks the MA to take... (Source: Family Practice News)
Source: Family Practice News - July 8, 2016 Category: Primary Care Source Type: news
MassDevice.com +5 | The top 5 medtech stories for June 24, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. InVivo Therapeutics touts case study in 1st spine scaffold implant
InVivo Therapeutics this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal...
Source: Mass Device - June 24, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
U.K. launches study of Dune Medical’s MarginProbe breast cancer device
Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors.
Paoli, Pa.-based Dune said the NHS’s National Institute of Health Research arm is funding a study to see whether MarginProbe reduces the need for further re-excision procedures after lumpectomy procedures.
The 460-patient study, led by Dr. Nigel Bundrud of the University Hospital of Southern Manchester, is a randomized, prospective, double arm trial. It’s designed to monitor the number of patients who...
Source: Mass Device - June 24, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Oncology Women's Health Dune Medical Devices Inc. Source Type: news
Has breast MRI been performed upside down?
A new phase 1 clinical trial evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer. Researchers demonstrated that considerable deformity of the breast and tumor position occurs when patients are imaged in the prone position. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 22, 2016 Category: Science Source Type: news
Has breast MRI been performed upside down?
(Brigham and Women's Hospital) A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22, 2016, evaluated the differences between pre-operative prone and supine MRI exams in 12 women undergoing lumpectomy for breast cancer. Researchers demonstrated that considerable deformity of the breast and tumor position occurs when patients are imaged in the prone position. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2016 Category: Cancer & Oncology Source Type: news
More Than Half A Million People Have Watched This Pregnancy Announcement
A brother's instant reaction to his sister's pregnancy announcement is a sweet reminder of how close siblings can be.
On Wednesday, Facebook page Love What Matters shared an old video of Lindsay MacPhee-Currie's pregnancy announcement. In the video, which was filmed in August 2014, she offers her older brother, Callum MacPhee, a bottle of wine at her home in Nova Scotia and jokes that she originally got it for herself, but that she can't "drink for the next nine months." In tears, her brother immediately hugs her. The announcement came as a shock to MacPhee-Currie's family, since doctors told her that her chances of c...
Source: Healthy Living - The Huffington Post - June 17, 2016 Category: Consumer Health News Source Type: news
Study backs laser prostate ablation with Medtronic’s Artemis
Laser ablation may be a feasible and safe treatment option for men with intermediate risk prostate cancer, according to a new study published in the Journal of Urology.
The treatment operates using magnetic resonance imaging to guide a laser fiber into a cancerous tumor in the prostate to destroy the tissue with extreme heat.
The study of the technique, funded by Medtronic (NYSE:MDT) and undertaken at UCLA, reported no serious adverse effects or changes in urinary or sexual function at 6-months post procedure.
“Our feeling was that if you can see prostate cancer using the fusion MRI and can put a needle in the spot ...
Source: Mass Device - June 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Clinical Trials Oncology Medtronic Source Type: news
Breast cancer treatment in Raleigh makes big difference
Treatment Terms
Cancer
Breast cancer
Cancer support services
Additional SEO Keywords
breast cancer, breast cancer treatment, chemo, chemotherapy, lumpectomy
SEO Meta Description
Breast cancer treatment available in Wake County
Sub-Title
Maintaining a normal schedule means better quality of life
Overview
For Joy Lathan, receiving her breast cancer treatment in Raleigh, near where she lives in and works, made a big difference. It allowed her to schedule chemotherapy and radiation treatments at Duke Raleigh Hospital, which ...
Source: dukehealth.org: Duke Health News - May 20, 2016 Category: Consumer Health News Authors: ak401 Source Type: news
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer
Objective: To quantify the journeys and CO emissions if women with breast cancer are treated with risk-adapted single-dose targeted intraoperative radiotherapy (TARGIT) rather than several weeks' course of external beam whole breast radiotherapy (EBRT) treatment.
Setting: (1) TARGIT-A randomised clinical trial ( 2 External 0 0 0 ISRCTN34086741 false http://www.controlled-trials.com/ISRCTN34086741 true false%>) which compared TARGIT with traditional EBRT and found similar breast cancer control, particularly when TARGIT was given simultaneously with lumpectomy, (2) 2 additional UK centres offering TARGIT.
Part...
Source: Current Awareness Service for Health (CASH) - May 10, 2016 Category: Consumer Health News Source Type: news
1 in 4 Women Will Need Additional Surgery After...
A recent study finds that 1 in 4 women will need additional surgery after a lumpectomy to get cancer-free margins. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - April 22, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Duke Breast Cancer Expert Named One of TIME’s 100 Most Influential People for 2016
Contact: Samiha KhannaPhone: 919-419-5069Email: samiha.khanna@duke.eduhttps://www.dukehealth.org
FOR IMMEDIATE RELEASE on Thursday, April 21, 2016
DURHAM, N.C. -- Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute, has been named one of TIME’s 100 most influential people for 2016 as a pioneer in her field.
One of the world’s foremost experts in early-stage breast cancers, Hwang has become an international leader calling for research to guide treatment for ductal carcinoma in situ (DCIS), in which abnormal cells are detected in the lining of a milk duct, but haven’t spread to other tissues.
DCIS...
Source: DukeHealth.org: Duke Health Features - April 22, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news
Breast Brachytherapy - SAVI Device for...
Learn about the SAVI breast brachytherapy device for reducing recurrence after a lumpectomy via accelerated partial breast irradiation. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - March 26, 2016 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
